Amphastar Pharmaceuticals, Inc. (AMPH)

Amphastar Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	182.78	151.61	144.3	156.1	126.35	92.64
Short-Term Investments	54.1	70.04	112.51	19.66	10.32	12.98
Cash & Short-Term Investments	236.88	221.65	256.81	175.76	136.67	105.62
Cash Growth	-18.19%	-13.69%	46.11%	28.60%	29.40%	23.73%
Accounts Receivable	144.64	136.29	114.94	88.8	78.8	66.01
Other Receivables	0.76	7.75	0.53	0.17	0.13	0.39
Receivables	145.39	144.04	115.47	88.98	78.93	66.39
Inventory	185.48	153.74	105.83	103.58	92.81	96.83
Prepaid Expenses	11.77	12.21	9.06	7.56	7.27	6.78
Restricted Cash	0.24	0.24	0.24	0.24	0.24	1.87
Other Current Assets	8.2	2.2	2.2	2.2	2.2	2.2
Total Current Assets	587.96	534.07	489.6	378.32	318.12	279.68
Property, Plant & Equipment	353.76	344.63	315.64	264.57	271.49	280.71
Long-Term Investments	5.91	11	15.21	2.41	3.99	-
Goodwill	3.16	3.05	3.22	3.13	3.31	3.94
Other Intangible Assets	581.37	587.61	610.08	34.17	35.56	36.68
Long-Term Deferred Tax Assets	71.12	71.12	53.25	38.53	22.4	24.98
Other Long-Term Assets	22.99	25.99	25.91	20.86	16.67	5.25
Total Assets	1,626	1,577	1,513	741.99	671.53	631.24
Accounts Payable	52.81	30.51	25.44	20.5	22.21	24.36
Accrued Expenses	105.94	111.57	54.75	46.19	44.17	45.95
Current Portion of Long-Term Debt	0.22	0.03	0.44	3.05	2.2	12.26
Current Portion of Leases	7.75	7.01	3.91	3	2.98	3.36
Current Income Taxes Payable	15.14	9.66	1.61	4.57	9.08	1.08
Other Current Liabilities	17.19	14.97	139.27	17.55	23.16	25.19
Total Current Liabilities	199.05	173.76	225.41	94.86	103.81	112.2
Long-Term Debt	603.48	601.41	588.96	72.84	74.38	33.58
Long-Term Leases	41.09	42.11	30.34	23.69	25.1	18.07
Long-Term Deferred Tax Liabilities	-	-	-	0.14	0.53	0.74
Other Long-Term Liabilities	28.58	25.3	26.18	21.79	22.18	17.92
Total Liabilities	874.99	845.17	873.49	213.33	226.01	182.51
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	509.11	505.4	486.06	455.08	422.42	410.06
Retained Earnings	594.07	568.79	409.27	271.72	180.34	117.77
Treasury Stock	-343.93	-332.71	-247.43	-189.52	-150.48	-121.81
Comprehensive Income & Other	-7.97	-9.18	-8.48	-8.62	-6.77	-3.72
Total Common Equity	751.28	732.3	639.42	528.66	445.52	402.31
Minority Interest	-	-	-	-	-	46.42
Shareholders' Equity	751.28	732.3	639.42	528.66	445.52	448.72
Total Liabilities & Equity	1,626	1,577	1,513	741.99	671.53	631.24
Total Debt	652.53	650.55	623.64	102.58	104.66	67.27
Net Cash (Debt)	-415.65	-428.9	-366.84	73.18	32.01	38.35
Net Cash Growth	-	-	-	128.62%	-16.53%	104.69%
Net Cash Per Share	-8.11	-8.24	-6.92	1.40	0.64	0.78
Filing Date Shares Outstanding	47.14	47.65	48.1	47.9	48.15	47.43
Total Common Shares Outstanding	47.67	47.62	48.07	48.11	47.71	47.5
Working Capital	388.91	360.31	264.19	283.46	214.31	167.48
Book Value Per Share	15.76	15.38	13.30	10.99	9.34	8.47
Tangible Book Value	166.76	141.64	26.13	491.36	406.65	361.69
Tangible Book Value Per Share	3.50	2.97	0.54	10.21	8.52	7.62
Land	7.46	7.42	7.48	7.45	7.62	7.72
Buildings	170.51	169.43	168.77	130.73	130.58	124.33
Machinery	326.61	313.38	291.43	237.74	235.26	238.15
Construction In Progress	40.91	36.69	18.68	50.84	41.19	43.98
Leasehold Improvements	42.09	42.01	41.69	31.54	29.22	30.03

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q